A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT 06588478 Brief Summary The main purpose of this study is to…
Read more arrow_forwardNCT 06588478 Brief Summary The main purpose of this study is to…
Read more arrow_forwardNCT 05583617 Brief Summary CO43923 is a platform study that will evaluate…
Read more arrow_forwardNCT 04929223 Brief Summary This open-label, exploratory study is designed to evaluate…
Read more arrow_forwardNCT 05789082 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05927571 Brief Summary The purpose of the study is to evaluate…
Read more arrow_forwardNCT 05981703 Brief Summary This is an open-label, multicenter, and nonrandomized dose…
Read more arrow_forwardNCT 06875310 Brief Summary This is a trial to evaluate the efficacy,…
Read more arrow_forwardNCT 06307431 Brief Summary The primary objective of the study is to…
Read more arrow_forwardNCT 05094336 Brief Summary The primary objective of Parts 1 and 2…
Read more arrow_forwardNCT 06750094 Brief Summary The purpose of this study is to compare…
Read more arrow_forward